Physician profile
Simone Thavaseelan
NPI 1053530782
$15,920.41
in general payments reported to CMS, 2019-2025
4 companies · $4,621 in 2025
The $4,621 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $3,225 · 2022: $200 · 2023: $3,398 · 2024: $4,332 · 2025: $4,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $524 · Travel and Lodging: $81.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,745.00 |
| Food and Beverage | $524.41 |
| Travel and Lodging | $81.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,763.37 | 2020-2025 | General - Kidney Stone Disease, General - Therapies, Advantage System |
| Coloplast Corp | $90.06 | 2019 | |
| Dornier Medtech America, INC | $54.64 | 2019 | |
| Cook Medical LLC | $12.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Thavaseelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.